Enthera Pharmaceuticals
Italian biotechnology company developing first-in-class biologics targeting the IGFBP3/TMEM219 pathway to transform the treatment of autoimmune conditions including Type 1 diabetes.
Website
https://www.enthera.com/Location
Milan, Italy
Founded
2016
Investors
1
Categories
biotech, autoimmune, biologics, therapeutics, clinical-stage
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Sofinnova Partners | Paris, France | biotech-focused | seedseries-a+3 | 23 |